JP2006524206A5 - - Google Patents

Download PDF

Info

Publication number
JP2006524206A5
JP2006524206A5 JP2006505223A JP2006505223A JP2006524206A5 JP 2006524206 A5 JP2006524206 A5 JP 2006524206A5 JP 2006505223 A JP2006505223 A JP 2006505223A JP 2006505223 A JP2006505223 A JP 2006505223A JP 2006524206 A5 JP2006524206 A5 JP 2006524206A5
Authority
JP
Japan
Prior art keywords
methyl
propyl
ethyl
dioxide
indole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006505223A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006524206A (ja
Filing date
Publication date
Priority claimed from GBGB0309221.0A external-priority patent/GB0309221D0/en
Application filed filed Critical
Publication of JP2006524206A publication Critical patent/JP2006524206A/ja
Publication of JP2006524206A5 publication Critical patent/JP2006524206A5/ja
Withdrawn legal-status Critical Current

Links

JP2006505223A 2003-04-23 2004-04-21 三環式インドール誘導体およびアルツハイマー病治療におけるそれらの使用法 Withdrawn JP2006524206A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0309221.0A GB0309221D0 (en) 2003-04-23 2003-04-23 Novel compounds
PCT/EP2004/004244 WO2004094430A1 (en) 2003-04-23 2004-04-21 Tricyclic indole derivatives and their use in the treatment of alzheimer’s disease

Publications (2)

Publication Number Publication Date
JP2006524206A JP2006524206A (ja) 2006-10-26
JP2006524206A5 true JP2006524206A5 (cg-RX-API-DMAC7.html) 2007-05-10

Family

ID=9957152

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006505223A Withdrawn JP2006524206A (ja) 2003-04-23 2004-04-21 三環式インドール誘導体およびアルツハイマー病治療におけるそれらの使用法

Country Status (16)

Country Link
US (1) US20060229302A1 (cg-RX-API-DMAC7.html)
EP (1) EP1620438A1 (cg-RX-API-DMAC7.html)
JP (1) JP2006524206A (cg-RX-API-DMAC7.html)
KR (1) KR20050111797A (cg-RX-API-DMAC7.html)
CN (1) CN1809573A (cg-RX-API-DMAC7.html)
BR (1) BRPI0409622A (cg-RX-API-DMAC7.html)
CA (1) CA2523291A1 (cg-RX-API-DMAC7.html)
CO (1) CO5700829A2 (cg-RX-API-DMAC7.html)
GB (1) GB0309221D0 (cg-RX-API-DMAC7.html)
IS (1) IS8135A (cg-RX-API-DMAC7.html)
MA (1) MA27674A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA05011365A (cg-RX-API-DMAC7.html)
NO (1) NO20055442L (cg-RX-API-DMAC7.html)
RU (1) RU2005136370A (cg-RX-API-DMAC7.html)
WO (1) WO2004094430A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200508041B (cg-RX-API-DMAC7.html)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1565428A1 (en) * 2002-11-27 2005-08-24 Elan Pharmaceuticals, Inc. Substituted ureas and carbamates
GB0328900D0 (en) * 2003-12-12 2004-01-14 Glaxo Group Ltd Novel compounds
US7763609B2 (en) 2003-12-15 2010-07-27 Schering Corporation Heterocyclic aspartyl protease inhibitors
GB0411404D0 (en) * 2004-05-21 2004-06-23 Glaxo Group Ltd Novel compounds
BRPI0515383A (pt) * 2004-09-21 2008-07-22 Pfizer Prod Inc n-etil hidroxietilamina útil no tratamento de condições do snc
GB0422766D0 (en) * 2004-10-13 2004-11-17 Glaxo Group Ltd Novel compounds
GB0422765D0 (en) * 2004-10-13 2004-11-17 Glaxo Group Ltd Novel compounds
GB0422755D0 (en) * 2004-10-13 2004-11-17 Glaxo Group Ltd Novel compounds
WO2006088705A1 (en) * 2005-02-14 2006-08-24 Wyeth Terphenyl guanidines as [beta symbol] -secretase inhibitors
GB0506562D0 (en) * 2005-03-31 2005-05-04 Glaxo Group Ltd Novel compounds
KR20080015079A (ko) 2005-04-08 2008-02-18 코멘티스, 인코포레이티드 베타 세크레타제 활성을 억제하는 화합물 및 이것의 사용방법
WO2007019078A2 (en) * 2005-08-03 2007-02-15 Merck & Co., Inc. Tricyclic beta-secretase inhibitors for the treatment of alzheimer's disease
WO2007061670A1 (en) * 2005-11-21 2007-05-31 Amgen Inc. Beta-secretase modulators and methods of use
US7872009B2 (en) 2005-11-21 2011-01-18 Amgen Inc. Beta-Secretase modulators and methods of use
US7745484B2 (en) 2005-11-21 2010-06-29 Amgen Inc. Beta-secretase modulators and methods of use
US7838676B2 (en) * 2005-11-21 2010-11-23 Amgen Inc. Beta-secretase modulators and methods of use
TW200901991A (en) 2007-05-25 2009-01-16 Amgen Inc Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
MX2009012608A (es) 2007-05-25 2009-12-07 Amgen Inc Compuestos de hidroxietil amina substituidos como moduladores de beta-secretasa y metodos de uso.
FR2919288B1 (fr) * 2007-07-27 2009-09-04 Sanofi Aventis Sa Derives de 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine-6- carboxamides, leur preparation et leur application en therapeutique.
FR2919285B1 (fr) 2007-07-27 2012-08-31 Sanofi Aventis Derives de 1-oxo-isoindoline-4-carboxamides et de 1-oxo- 1,2,3,4-tetrahydroisoquinoleine-5-carboxamides, leur preparation et leur application en therapeutique.
ATE512968T1 (de) * 2007-07-27 2011-07-15 Sanofi Aventis 1,2,3,4-tetrahydropyrrolo(1,2-a)pyrazin-6- carboxamid und 2,3,4,5-tetrahydropyrrolo(1,2-a)- diazepin-7-carboxamid- derivate, ihre herstellung und therapeutische verwendung
FR2919286A1 (fr) 2007-07-27 2009-01-30 Sanofi Aventis Sa Derives de derives de 1-oxo-1,2-dihydroisoquinoleine-5- carboxamides et de 4-oxo-3,4-dihydroquinazoline-8- carboxamides,leur preparation et leur application en therapeutique.
FR2919289B1 (fr) * 2007-07-27 2009-09-04 Sanofi Aventis Sa Derives de 2,3,4,5-tetrahydropyrrolo[1,2-a][1,4]- diazepine-7-carboxamides, leur preparation et leur application en therapeutique.
US9096541B2 (en) 2012-03-29 2015-08-04 Oklahoma Medical Research Foundation Inhibition of memapsin 1 cleavage in the treatment of diabetes
EP3684767B1 (en) * 2017-09-22 2024-04-24 Jubilant Epipad LLC Heterocyclic compounds as pad inhibitors
US12043631B2 (en) 2017-10-13 2024-07-23 Purdue Research Foundation BACE1 inhibitors for the treatment of Alzheimer's disease
US11214579B2 (en) 2017-10-13 2022-01-04 Purdue Research Foundation BACE1 inhibitors for the treatment of Alzheimer's disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998033795A1 (en) * 1997-02-04 1998-08-06 The Regents Of The University Of California Nanomolar, non-peptide inhibitors of cathepsin d
US6207664B1 (en) * 1998-11-25 2001-03-27 Pfizer Inc. Squalene synthetase inhibitor agents
CA2410680A1 (en) * 2000-06-30 2002-01-10 Elan Pharmaceuticals, Inc. Compounds to treat alzheimer's disease

Similar Documents

Publication Publication Date Title
JP2006524206A5 (cg-RX-API-DMAC7.html)
RU2005136370A (ru) Трициклические индоловые производные и их применение в лечении болезни альцгеймера
JP7278359B2 (ja) Shp2の活性を阻害するための化合物および組成物
JP2014511893A5 (cg-RX-API-DMAC7.html)
ES2959419T3 (es) Formulaciones secas por aspersión
JP2018521017A5 (cg-RX-API-DMAC7.html)
KR20190041471A (ko) 케모카인 수용체 조절제 및 이의 용도
JP2010509366A5 (cg-RX-API-DMAC7.html)
JP2020531447A5 (cg-RX-API-DMAC7.html)
JP2014526501A5 (cg-RX-API-DMAC7.html)
JP2006510716A5 (cg-RX-API-DMAC7.html)
JP2011527683A5 (cg-RX-API-DMAC7.html)
US10189813B2 (en) Formylated N-heterocyclic derivatives as FGFR4 inhibitors
JP2010536761A5 (cg-RX-API-DMAC7.html)
TR201802093T4 (tr) Terapötik terapilerde kullanım için akt inhibitör bileşiği ve abirateron kombinasyonu.
JP2009534405A5 (cg-RX-API-DMAC7.html)
JP2015519368A5 (cg-RX-API-DMAC7.html)
JP2018531987A5 (cg-RX-API-DMAC7.html)
CN108430475B (zh) 用于治疗慢性咳嗽的奥维匹坦
JP2018515563A (ja) 化合物
JP2013520420A5 (cg-RX-API-DMAC7.html)
JP2017525721A (ja) 認知欠損または認知障害に伴って進行する神経障害のおよび神経変性疾患の処置および予防のための製品
JP2007513913A5 (cg-RX-API-DMAC7.html)
RU2006124863A (ru) Трициклические производные индолгидроксиэтиламина и их применение при лечении болезни альцгеймера
JP2016508135A5 (cg-RX-API-DMAC7.html)